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PreviewsRestoring Permeability Barrier
Function to Outer Membrane
A recent issue of Cell published two papers resulting
from the collaboration between the Kahne and Sil-
havy laboratories [1, 2]. These studies, possibly initi-
ated as an effort to identify the target of action of van-
comycin with lipophilic substitutions, resulted in the
discovery of a protein complex involved in the assem-
bly of outer membrane proteins.
Daniel Kahne’s group showed earlier that chlorobiphe-
nyl (CBP)-vancomycin, which is effective on vancomy-
cin-resistant gram-positive bacteria, unexpectedly acts
by inhibiting the transglycosylation reaction of pepti-
doglycan biosynthesis, rather than by the “classical”
mechanism of binding to the D-Ala-D-Ala portion of the
peptidoglycan-biosynthetic intermediate [3]. Research-
ers in Tom Silhavy’s laboratory had used the genetic
approach, specifically the isolation of mutants in Esch-
erichia coli, in the study of assembly of the cell enve-
lope. It was natural for these two laboratories to try to
isolate CBP-vancomycin-resistant mutants of E. coli,
which could produce confirmation of the identity of the
target of this antibiotic. The results were not only unex-
pected, but even more, they were intriguing and impor-
tant. Gram-negative bacteria such as E. coli are sur-
rounded by an outer membrane (OM) permeability
barrier that normally prevents the entry of vancomycin
and CBP-vancomycin (Figure 1A), and thus an imp mu-
tant, defective in the assembly of lipopolysaccharide
(LPS) into the OM (Figure 1B), was used in this experi-
ment. In retrospect, therefore, it is not surprising that
the resistant mutants had OM with better barrier prop-
erties rather than alterations of the drug target. How-
ever, the mutations occurred in a gene of hitherto un-
known function, yfgL [1], whose product was found to
assemble into a multiprotein complex, involved in OM
protein assembly, containing three other proteins (YaeT,
YfiO, and NlpB) [2]. Of these, YaeT is a homolog of
Omp85, whose function in OM protein assembly was
previously reported [4], but the functions of the other
three proteins were totally unknown before this work.
Not only is the discovery of this multiprotein complex
exciting, the data show functional interaction between
the LPS assembly machinery and the protein assembly
machinery of OM.
In order to understand the results of Ruiz et al. [1]
and Wu et al. [2], we must realize that the OM, a unique
structure for Gram-negative bacteria (such as E. coli),
is an effective permeability barrier and makes these
bacteria inherently resistant to many antibiotics. Build-
ing membranes of very low permeability, however, is
not an easy task. First, the phospholipid bilayers that
form the matrix of most biological membranes allow
rapid permeation of lipophilic molecules, and most an-
tibiotics (except those of the β-lactam class and a few
others) must be lipophilic as they have to traverse thecytoplasmic membrane quickly and spontaneously to
reach their targets in the cytoplasm, such as ribo-
somes, RNA polymerase, or DNA topoisomerases. In
order to overcome this problem, the OM bilayer is
asymmetric, and its outer leaflet is almost completely
composed of an unusual lipid, LPS [5]. The lipid portion
of LPS (“lipid A”) contains up to seven residues of satu-
rated fatty acids, which produce a lipid interior of very
low fluidity [6]. Thus the OM’s LPS/phospholipid bilayer
is much less permeable to lipophilic solutes than the
phospholipid bilayer [7]. However, the steps involved in
the assembly and maintenance of this extremely asym-
metric bilayer are not known. Second, bacteria must
allow the passage of hydrophilic nutrient molecules
across the OM, and for that purpose they produce nar-
row nonspecific channels (porins) as well as specific
channels and transporters [6]. Presumably because
these proteins must be inserted into the OM after their
full export across the cytoplasmic membrane, practi-
cally all OM proteins have the final conformation of
membrane-spanning β-barrels, in contrast to the inner
membrane proteins that cross the bilayer usually as
transmembrane helices. But again, the mechanism of
assembly of these proteins into the OM is not clear.
Defects in the OM can lead to increased permeability
to inhibitors. The classical case is that of the “deep
rough” mutants, which produce LPS of severely trun-
cated sugar chains and become hypersusceptible to
lipophilic inhibitors such as novobiocin, rifampicin, and
erythromycin. (Apparent octanol/water partition coeffi-
cients are 48.8, 16.0, and 0.89 for these compounds,
respectively [8].) The most obvious explanation of these
results is that the outer leaflet composed of the de-
fective LPS serves as a less effective barrier. However,
extensive studies in 1970s showed that the OM perme-
ability is increased via an indirect mechanism [9]. Thus
the presence of these defective LPS molecules inhibits
the insertion of many OM proteins, and the empty
spaces in the OM become filled with phospholipids,
generating phospholipid bilayers that have a much
higher permeability than the normal LPS/phospholipid
asymmetric bilayer (Figure 1B). (The alternative solution
of shrinking the surface area of the OM is not possible,
because the rigid peptidoglycan is located underneath
the OM.) In these mutants the OM shows little signs of
leakiness for periplasmic proteins, and the integrity of
its structure is maintained so that the cells remain resis-
tant to vancomycin and bacitracin (except in some
strains with extreme LPS defects) [9].
There are, however, E. colimutants that become hyp-
ersusceptible to peptide (or glycopeptide) antibiotics
such as vancomycin and bacitracin, which are quite hy-
drophilic overall with measured octanol/water partition
coefficients less than 0.1 [8]. Since such compounds
cannot easily dissolve in the hydrocarbon interior of the
OM, one must assume that the mutant OM contains
transient imperfections or “cracks” that allow the diffu-
sion of these hydrophilic drugs into the periplasm (Fig-
ure 1B). Indeed, this interpretation is consistent with
Chemistry & Biology
508Figure 1. Permeation of Large Inhibitors
across OM
(A) Wild-type E. coli, where the asymmetric
LPS/phospholipid bilayer and the narrow
porin channel effectively block the entry of
most large inhibitors.
(B) The imp4213 mutant. Here the decreased
incorporation of LPS into OM by the mutant
Imp4213 protein generates both the bilayer
containing a phospholipid bilayer domain,
and transient openings in OM. The former al-
lows the diffusion of lipophilic drugs (eryth-
romycin, novobiocin, and rifampicin), and
the latter allows the diffusion of both hydro-
philic antibiotics (vancomycin and bacitra-
cin) and amphiphilic compounds (CBP-van-
comycin, moenomycin, and bile salts).
(C) The imp4213 yfgL double mutant. The in-
activation of YfgL alters the export of OM
proteins, and the effective width of the gaps
in the OM is narrowed. The phospholipid bi-
layer still allows the passage of lipophilic
compounds, and the gap allows the entry of
both vancomycin and bacitracin. However,
the entry of large, amphiphilic compounds,
shown here hypothetically as micelles, now
becomes difficult.the finding that strains with this phenotype have de- r
pfects that affect the physical assembly and enlarge-
wment of the cell envelope, for example leaky mutations
tin the early genes of the synthesis of the lipid A (such
ias lpxA and lpxC [earlier called envA]) [8, 9], mutations
yin peptidoglycan metabolism [10], or strains in which
aexogenous channels or misfolded proteins are inserted
ointo the OM [11, 12]. Most of these strains are also hy-
tpersusceptible to lipophilic agents. Another example is
athe mutants that are defective in the incorporation of
hthe unsaturated fatty acid chain into lipid A [13] and
uthat become hypersusceptible to vancomycin at low
atemperature, presumably because the LPS leaflet be-
pcomes frozen and brittle, a situation reminiscent of the
tcold CaCl2 treatment procedure for E. coli, which allows
sthe entry of not only DNA but also proteins [14] through
tthe transient cracks of OM.
gIn the study of Ruiz et al. [1], the defect in Imp pro-
stein, which assembles LPS into the OM, leads not only
sto hypersusceptibility to hydrophobic agents but also
tto vancomycin and bacitracin. This is what is expected
sfrom the phenotype of strains exporting insufficient
famounts of LPS to the OM, as described above. What
cis most interesting, however, is that the mutants with
[increased resistance to CBP-vancomycin and moeno-
p
mycin (another large, amphiphilic antibiotic) contain
loss-of-function mutations in the gene yfgL, whose
product was shown by Wu et al. [2] to be a part of A
multiprotein complex involved in the assembly of OM
proteins. In fact, yfgL mutants were shown to export I
OM proteins more slowly [1]. The imp yfgL double mu-
tant is still susceptible to vancomycin and bacitracin H
[1]: the integrity of OM therefore should still be compro- D
mised (Figure 1C). The resistance of the double mutant U
to CBP-vancomycin, moenomycin, and bile salts could 4
Bmean that the cracks in OM have now become “nar-ower” (Figure 1C), excluding these amphiphilic com-
ounds that may form micelles. The mechanism
hereby decreased assembly of OM proteins produces
his effect is still unclear, especially because mutations
n other genes in the OM protein export complex (yaeT,
fiO, nlpB) do not produce this phenotype. One would
ctually expect wider, not narrower, cracks if the export
f both LPS and proteins to OM is decreased, although
he requirement for slow growth for the double mutant
t least is as expected from this line of reasoning. Per-
aps the way we imagine the transient cracks as in Fig-
re 1B is overly naive (and energetically too unfavor-
ble); the real opening may arise in between the
roteins, and thus the nature, in addition to the size, of
he opening might be at issue. In any case these
tudies not only led to the discovery of new multipro-
ein machinery for OM protein assembly, but also sug-
est that there is much more to be explored on such
eemingly simple processes as the spontaneous diffu-
ion of drugs across OM. The approach of using small
oxic chemicals to understand the dynamics of OM as-
embly and function indeed looks quite promising. In
act, an inner membrane protein needed for vancomy-
in resistance of E. coli has previously been reported
15]. Could this protein perhaps be a part of the OM
rotein assembly complex or at least interact with it?
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